APBA2 and Borderline personality disorder: In summary, while epigenome-wide screens have highlighted PXDN, APBA2/APBA3, and MCF2 as tentative epigenetic markers in BPD, linking DNA methylation to early trauma exposure or clinical outcomes, these findings remain provisional.